Ligand-independent mutations drive downstream activation of the Wnt cascade, through mutational inactivation of APC, the key tumour suppressor gene (80%), or gain-of-function CTNNB1 mutations (<5%) which also result in ligand-independent mutations. This evidence concerns the gene APC and neoplasm.